Sharissa L Latham
9PUBLICATIONS
89CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Nov 28, 2025
Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma.Jeremy Z R Han, Monica Phimmachanh, Jordan F Hastings
|Feb 21, 2025
Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancer.Xue Yang, Xiuquan Ma, Tianyue Zhao
|Aug 28, 2023
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer.Jessica L Chitty, Michelle Yam, Lara Perryman
|May 01, 2023
Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouse.James R W Conway, Sean C Warren, Young-Kyung Lee
|Mar 03, 2023
Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma.Jordan F Hastings, Sharissa L Latham, Alvin Kamili
|Dec 01, 2022
Non-kinase targeting of oncogenic c-Jun N-terminal kinase (JNK) signaling: the future of clinically viable cancer treatments.Sharissa L Latham, Yolande E I O'Donnell, David R Croucher
Pageof 2
Frequent Collaborators
7 joint publications
David R Croucher
4 joint publications
Paul Timpson
3 joint publications
Antonia L Cadell
2 joint publications
Manuel H Taft
2 joint publications
Barbara Klink
2 joint publications
Nataliya Di Donato
2 joint publications
Murray Norris
2 joint publications
Yolande Ei O'Donnell
2 joint publications
Max Nobis
2 joint publications
Alvin Kamili
